CZ211299A3 - Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů - Google Patents
Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů Download PDFInfo
- Publication number
- CZ211299A3 CZ211299A3 CZ992112A CZ211299A CZ211299A3 CZ 211299 A3 CZ211299 A3 CZ 211299A3 CZ 992112 A CZ992112 A CZ 992112A CZ 211299 A CZ211299 A CZ 211299A CZ 211299 A3 CZ211299 A3 CZ 211299A3
- Authority
- CZ
- Czechia
- Prior art keywords
- factor
- derivative
- vvf
- von
- von villebrand
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0217896A AT405740B (de) | 1996-12-13 | 1996-12-13 | Von willebrand-faktor-derivat sowie ein verfahren zur isolierung von proteinen |
Publications (1)
Publication Number | Publication Date |
---|---|
CZ211299A3 true CZ211299A3 (cs) | 1999-09-15 |
Family
ID=3529390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CZ992112A CZ211299A3 (cs) | 1996-12-13 | 1997-11-19 | Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0954533A1 (fr) |
JP (1) | JP2001506987A (fr) |
AT (1) | AT405740B (fr) |
CZ (1) | CZ211299A3 (fr) |
HU (1) | HUP9903789A3 (fr) |
WO (1) | WO1998025969A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994310A (en) * | 1998-09-03 | 1999-11-30 | Bayer Corporation | Peptide ligands for affinity purification of human Factor VIII |
BRPI0519562A2 (pt) | 2004-12-27 | 2009-01-27 | Baxter Int | construÇço proteinÁcea, complexo, mÉtodo para prolongar a meia-vida in vivo de fator viii (fviii) ou um derivado biologicamente ativo do mesmo composiÇço farmacÊutica, e, mÉtodo para formar uma construÇço proteinÁcea |
CA2647314A1 (fr) | 2006-03-31 | 2007-11-08 | Baxter International Inc. | Facteur viii pegyle |
US7645860B2 (en) | 2006-03-31 | 2010-01-12 | Baxter Healthcare S.A. | Factor VIII polymer conjugates |
CA2740919A1 (fr) * | 2008-10-21 | 2010-04-29 | Baxter International Inc. | Formulations de vwf recombinant lyophilise |
JP2015507929A (ja) * | 2012-02-14 | 2015-03-16 | ポートラ ファーマシューティカルズ, インコーポレイテッド | 第Xa因子阻害剤に対する組み換え拮抗剤を製作するためのプロセス |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI86885C (fi) * | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
DE19521313A1 (de) * | 1995-06-12 | 1996-12-19 | Max Planck Inst Fuer Physiolog | Verfahren zur affinitätschromatographischen Aufreinigung von Faktor VIII |
SE9503380D0 (sv) * | 1995-09-29 | 1995-09-29 | Pharmacia Ab | Protein derivatives |
-
1996
- 1996-12-13 AT AT0217896A patent/AT405740B/de not_active IP Right Cessation
-
1997
- 1997-11-19 EP EP97913009A patent/EP0954533A1/fr not_active Withdrawn
- 1997-11-19 CZ CZ992112A patent/CZ211299A3/cs unknown
- 1997-11-19 JP JP52600398A patent/JP2001506987A/ja active Pending
- 1997-11-19 WO PCT/AT1997/000253 patent/WO1998025969A1/fr not_active Application Discontinuation
- 1997-11-19 HU HU9903789A patent/HUP9903789A3/hu unknown
Also Published As
Publication number | Publication date |
---|---|
HUP9903789A2 (hu) | 2000-03-28 |
ATA217896A (de) | 1999-03-15 |
AT405740B (de) | 1999-11-25 |
HUP9903789A3 (en) | 2002-01-28 |
JP2001506987A (ja) | 2001-05-29 |
WO1998025969A1 (fr) | 1998-06-18 |
EP0954533A1 (fr) | 1999-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5880265A (en) | Method for isolation of highly pure von willebrand factor | |
EP1863920B1 (fr) | Procédé d'isolation ameliorée des protéines de recombinaison | |
AU645172B2 (en) | Process for an industrial-scale preparation of a standardized human von Willebrand factor concentrate of very high purity and suitable for therapeutic use | |
CA1083959A (fr) | Procede de production d'une immunoglobuline intraveineuse | |
FI101476B (fi) | Menetelmä kalsiumista riippuvan proteiini C:n vastaisen monoklonaalise n vasta-aineen valmistamiseksi | |
US6005077A (en) | Use of von willebrand factor and pharmaceutical formulation | |
JP4250769B2 (ja) | 高度に精製されたvWFまたは因子VIII/vWF複合体を得る方法 | |
JPS63152396A (ja) | フォン・ウィレブラント因子の結合を抑制するペプチド | |
US4774323A (en) | Purification of von Willebrand Factor solutions using gel permeation chromatography | |
WO2021062263A1 (fr) | Procédés d'évaluation de polymères modifiés par un polypeptide dans des compositions | |
US6034222A (en) | Method for the separation of recombinant pro-factor IX from recombinant factor IX | |
CZ211299A3 (cs) | Derivát von Willebrandova faktoru, zařízení tento derivát obsahující a způsob isolace proteinů | |
US5710254A (en) | Purification of von Willebrand factor by affinity chromatography | |
US20020019036A1 (en) | Von willebrand factor derivatives and methods of isolating proteins that bind to von willebrand factor | |
RU2734783C2 (ru) | Способ отделения фактора viii от продуктов крови | |
EP0239644A1 (fr) | Nouvelle substance physiologiquement active limitant la coagulation du sang | |
JP2778086B2 (ja) | 第x▲iii▼因子のアフイニテイクロマトグラフイーによる精製法 | |
CZ290186B6 (cs) | Způsob výroby frakce s inaktivovanými viry obsahující faktor VIII chromatografickými metodami a frakce připravitelná tímto způsobem | |
Yamamoto et al. | von Willebrand factor antigen in urine | |
EP1094077A1 (fr) | Nouveau peptide lie par une chaine de sucres et similaire a la thrombomoduline | |
Thomas | Studies on the third component of complement | |
de Lille | Burnouf-Radosevich et a1. | |
MXPA97003470A (en) | Factor v purification process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PD00 | Pending as of 2000-06-30 in czech republic |